ストックスクリーナーアプリを入手
26.57
3.31%
-0.91
アフターアワーズ：
26.57
前日終値:
$27.48
開ける：
$27.45
24時間の取引高:
940.38K
Relative Volume:
1.57
時価総額：
$1.90B
収益：
$81.26M
当期純損益:
$-102.66M
株価収益率:
-19.43
EPS:
-1.3678
ネットキャッシュフロー:
$-77.62M
1週間 パフォーマンス:
+1.26%
1か月 パフォーマンス:
+1.92%
6か月 パフォーマンス:
+13.30%
1年 パフォーマンス:
+61.13%
1日の値動き範囲:
$26.38
$27.55
1週間の範囲:
$25.81
$27.86
52週間の値動き範囲:
$15.81
$31.34
Zymeworks Inc. Stock (ZYME) Company Profile
名前
Zymeworks Inc.
セクター
電話
604-678-1388
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Compare ZYME vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
26.57 | 1.88B | 81.26M | -102.66M | -77.62M | -1.3678 |
VRTX
Vertex Pharmaceuticals Inc
|
508.34 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.85 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.32 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
154.04 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
190.95 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-12-03 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-10-24 | 再開されました | Wells Fargo | Equal Weight |
| 2025-10-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-10-10 | 開始されました | B. Riley Securities | Buy |
| 2025-05-20 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-11-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 再開されました | Wells Fargo | Overweight |
| 2023-01-04 | 繰り返されました | H.C. Wainwright | Neutral |
| 2022-12-20 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 再開されました | Wells Fargo | Overweight |
| 2022-05-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-03-15 | 開始されました | Evercore ISI | Outperform |
| 2021-12-10 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Neutral |
| 2021-10-07 | 開始されました | Jefferies | Hold |
| 2021-03-31 | 開始されました | Credit Suisse | Outperform |
| 2021-02-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 再開されました | H.C. Wainwright | Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-06 | 開始されました | SVB Leerink | Outperform |
| 2020-01-10 | 開始されました | Wolfe Research | Outperform |
| 2019-12-09 | 開始されました | JP Morgan | Neutral |
| 2019-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
| 2019-09-30 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 開始されました | Stifel | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2018-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 開始されました | Raymond James | Outperform |
すべてを表示
Zymeworks Inc. (ZYME) 最新ニュース
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 238,026 Shares of Zymeworks Inc. $ZYME - MarketBeat
Wellington Management Group LLP Takes $2.88 Million Position in Zymeworks Inc. $ZYME - MarketBeat
Legal & General Group Plc Makes New $1.13 Million Investment in Zymeworks Inc. $ZYME - MarketBeat
Bank of New York Mellon Corp Acquires New Holdings in Zymeworks Inc. $ZYME - MarketBeat
JPMorgan Chase & Co. Boosts Zymeworks (NASDAQ:ZYME) Price Target to $33.00 - MarketBeat
Zymeworks (NASDAQ:ZYME) Hits New 1-Year HighTime to Buy? - MarketBeat
Zymeworks stock hits 52-week high at 30.75 USD - Investing.com
Zymeworks stock hits 52-week high at 30.75 USD By Investing.com - Investing.com Nigeria
ZJM stock holds near its latest trade. Zymeworks data still drives the setup - ad-hoc-news.de
Enterprise value to revenue forward of Zymeworks Inc. – NASDAQ:ZYME - TradingView
Man Group plc Invests $5.51 Million in Zymeworks Inc. $ZYME - marketbeat.com
4,251,030 Shares in Zymeworks Inc. $ZYME Bought by BlackRock Inc. - marketbeat.com
Zymeworks stock holds near $28.27 as market cap tops $2.01 billion - ad-hoc-news.de
FY2026 EPS Estimates for Zymeworks Raised by HC Wainwright - MarketBeat
Zymeworks (ZYME), What Is Behind The Renewed Attention? - Yahoo Finance
Zymeworks shifts to revenue growth after FDA ap... - Pluang
HC Wainwright Has Strong Estimate for Zymeworks Q3 Earnings - marketbeat.com
Zymeworks moves higher as Street cheers Ziihera regimen approval - Seeking Alpha
Jazz Pharmaceuticals Wins FDA Approval For Two Advanced Gastric Cancer Regimens - Sahm
Zymeworks stock hits 52-week high at 29.81 USD By Investing.com - Investing.com South Africa
Zymeworks stock rating reiterated at Market Outperform by Citizens - Investing.com India
Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued? - sahmcapital.com
Zymeworks Announces FDA Approval of Ziihera-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma and $250 Million Milestone Payment from Jazz Pharmaceuticals - quiverquant.com
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma - NTB Kommunikasjon
Deutsche Bank AG Buys Shares of 397,190 Zymeworks Inc. $ZYME - MarketBeat
Theravance (NASDAQ: TBPH) sets vote on cash buyout with ampreloxetine CVR upside - Stock Titan
Enterprise value to revenue forward of Zymeworks Inc. – SWB:ZA8 - TradingView
Zymeworks (ZYME) Session Brief: Climbs 2.69% to $25.99 in the Latest Session; Reference Levels: $24.69 and $27.29 Define the Nearby Reference Levels at the ClosePCR Spike - vinanet.vn
How Zymeworks’ Bigger Loss, Buyback and Milestones Pivot At Zymeworks (ZYME) Has Changed Its Investment Story - simplywall.st
ZYME Q2 2026 Earnings: Wider-than-Expected Loss of -$0.62 per Share Reflects Clinical-Stage InvestmentProduct Revenue Analysis - vinanet.vn
Zymeworks Inc. (ZYME) stock price, news, quote and history - Yahoo Finance Australia
Q3 Earnings Estimate for Zymeworks Issued By HC Wainwright - MarketBeat
Zymeworks Inc. (ZYME) Stock Price, News, Quote & History - Yahoo! Finance Canada
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - Yahoo Finance
HC Wainwright Issues Negative Outlook for Zymeworks Earnings - MarketBeat
Zymeworks Announces Participation in Upcoming Investor Conferences - Macau Business
Zymeworks Inc. to Participate in Upcoming Investor Conferences in September - Quiver Quantitative
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update - TradingView
Zymeworks (ZYME) Is Up 7.3% After Q2 Swing Back to Net LossesWhat's Changed - simplywall.st
Assenagon Asset Management S.A. Has $32.73 Million Stake in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Zymeworks (ZYME) Stock Rich Valuation Meets Widening Losses - Sahm
Zymeworks Inc (ZYME) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
What is HC Wainwright's Forecast for Zymeworks Q2 Earnings? - MarketBeat
Zymeworks Inc. (ZYME): Analyst Consensus and Potential 72% Upside Make This Biotech Stock Worth Watching - DirectorsTalk Interviews
Is Zymeworks Inc (ZYME) Facing Challenges After Q2 Earnings Miss? GF Score: 65/100, Revenue at $4.6M - GuruFocus
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results - The Manila Times
Zymeworks Inc. Stock 12‑Month Price Target Raised to $40, Implies 73% Upside - TradingView
Zymeworks Inc. (ZYME) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Zymeworks Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Zymeworks Inc. Q2 2026: Revenue $4.6M, EPS $(0.62) — 10-Q Summary - TradingView
Zymeworks Inc. (ZYME) 財務データ
収益
当期純利益
現金流量
EPS
0.88%
大文字化:
|
ボリューム (24 時間):